Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,984 public trials 1,831 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

STI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic Leukemia

NCT00015860

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +20 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Oregon Cancer Institute Portland, Oregon, United States
View Trial Details
Completed

Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma

NCT00045539

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham, Alabama, United States
  • H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View Trial Details
Completed

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma

NCT00003150

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • MBCCOP - Gulf Coast Mobile, Alabama, United States
  • CCOP - Greater Phoenix Phoenix, Arizona, United States
  • Veterans Affairs Medical Center - Phoenix (Hayden) Phoenix, Arizona, United States
  • Veterans Affairs Medical Center - Tucson Tucson, Arizona, United States
View all 91 locations
View Trial Details
Completed

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT00006008

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 71 locations
View Trial Details

Related conditions